See more : Evrofarma SA (EVROF.AT) Income Statement Analysis – Financial Results
Complete financial analysis of Merit Medical Systems, Inc. (MMSI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Merit Medical Systems, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Ind-Swift Laboratories Limited (INDSWFTLAB.BO) Income Statement Analysis – Financial Results
- SLANG Worldwide Inc. (SLGWF) Income Statement Analysis – Financial Results
- Trainers’ House Oyj (TRH1V.HE) Income Statement Analysis – Financial Results
- Biotechnologies Assets SA (BST.MC) Income Statement Analysis – Financial Results
- Happiness and D Co.,Ltd. (3174.T) Income Statement Analysis – Financial Results
Merit Medical Systems, Inc. (MMSI)
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.26B | 1.15B | 1.07B | 963.88M | 994.85M | 882.75M | 727.85M | 603.84M | 542.15M | 509.69M | 449.05M | 394.29M | 359.45M | 296.76M | 257.46M | 227.14M | 207.77M | 190.67M | 166.59M | 151.40M | 135.95M | 116.23M | 104.04M | 91.45M | 78.00M | 68.40M | 60.60M | 50.50M | 42.60M | 33.30M | 25.40M | 18.40M | 10.50M | 4.40M | 1.40M |
| Cost of Revenue | 673.49M | 631.88M | 589.42M | 562.70M | 562.49M | 487.98M | 401.60M | 338.81M | 306.37M | 284.47M | 254.68M | 212.30M | 193.98M | 168.26M | 148.66M | 133.87M | 127.98M | 117.60M | 97.49M | 83.91M | 75.23M | 67.71M | 65.94M | 56.50M | 44.30M | 39.60M | 35.10M | 26.90M | 23.30M | 17.40M | 12.30M | 7.60M | 3.80M | 2.00M | 1.70M |
| Gross Profit | 583.87M | 519.10M | 485.33M | 401.18M | 432.37M | 394.77M | 326.25M | 265.03M | 235.78M | 225.22M | 194.37M | 181.99M | 165.47M | 128.50M | 108.80M | 93.27M | 79.79M | 73.08M | 69.09M | 67.49M | 60.72M | 48.52M | 38.10M | 34.94M | 33.70M | 28.80M | 25.50M | 23.60M | 19.30M | 15.90M | 13.10M | 10.80M | 6.70M | 2.40M | -300.00K |
| Gross Profit Ratio | 46.44% | 45.10% | 45.16% | 41.62% | 43.46% | 44.72% | 44.82% | 43.89% | 43.49% | 44.19% | 43.28% | 46.16% | 46.03% | 43.30% | 42.26% | 41.06% | 38.40% | 38.33% | 41.48% | 44.58% | 44.67% | 41.74% | 36.62% | 38.21% | 43.21% | 42.11% | 42.08% | 46.73% | 45.31% | 47.75% | 51.57% | 58.70% | 63.81% | 54.55% | -21.43% |
| Research & Development | 82.73M | 75.51M | 71.25M | 57.54M | 65.62M | 59.53M | 51.40M | 45.23M | 40.81M | 36.63M | 33.89M | 27.80M | 21.94M | 15.34M | 11.17M | 9.16M | 8.69M | 8.58M | 6.99M | 5.08M | 4.63M | 4.01M | 4.12M | 3.86M | 3.60M | 3.20M | 4.40M | 2.50M | 2.30M | 2.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 373.68M | 342.53M | 335.69M | 297.72M | 327.27M | 276.02M | 229.13M | 184.40M | 156.35M | 147.89M | 128.64M | 122.11M | 104.50M | 87.62M | 64.79M | 53.13M | 48.13M | 45.49M | 38.58M | 35.07M | 30.47M | 27.73M | 24.04M | 23.30M | 20.40M | 17.50M | 15.70M | 14.30M | 12.80M | 10.20M | 9.10M | 8.00M | 4.70M | 2.10M | 0.00 |
| Other Expenses | 3.52M | 966.00K | -2.51M | -2.28M | -537.00K | 63.00K | -872.00K | -773.00K | -386.00K | 18.00K | -216.00K | -1.65M | 5.84M | 8.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| Operating Expenses | 459.93M | 418.04M | 406.94M | 355.26M | 392.89M | 335.55M | 280.54M | 229.63M | 197.16M | 184.53M | 162.53M | 149.90M | 126.44M | 102.95M | 75.96M | 62.29M | 56.82M | 54.07M | 45.57M | 40.15M | 35.09M | 31.74M | 28.16M | 31.48M | 27.60M | 23.50M | 22.80M | 19.20M | 16.80M | 13.90M | 10.50M | 9.10M | 5.20M | 2.30M | 100.00K |
| Cost & Expenses | 1.13B | 1.05B | 996.36M | 917.96M | 955.38M | 823.53M | 682.14M | 568.44M | 503.53M | 468.99M | 417.21M | 362.20M | 320.42M | 271.21M | 224.62M | 196.16M | 184.80M | 171.66M | 143.06M | 124.06M | 110.32M | 99.45M | 94.10M | 87.99M | 71.90M | 63.10M | 57.90M | 46.10M | 40.10M | 31.30M | 22.80M | 16.70M | 9.00M | 4.30M | 1.80M |
| Interest Income | 2.46M | 439.00K | 769.00K | 604.00K | 0.00 | 1.20M | 381.00K | 81.00K | 272.00K | 217.00K | 255.00K | 226.00K | 129.00K | 34.00K | 178.00K | 781.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 15.51M | 6.34M | 5.26M | 9.99M | 12.41M | 10.36M | 7.74M | 8.80M | 6.23M | 8.83M | 8.04M | 604.00K | 789.00K | 596.00K | 28.00K | 17.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 101.29M | 92.20M | 95.78M | 106.82M | 104.36M | 69.55M | 53.58M | 43.76M | 37.43M | 35.93M | 32.54M | 22.53M | 19.19M | 14.86M | 12.27M | 10.24M | 9.31M | 8.10M | 5.64M | 4.49M | 4.23M | 4.38M | 4.56M | 4.32M | 3.60M | 2.80M | 2.70M | 2.40M | 1.70M | 1.60M | 1.40M | 1.10M | 500.00K | 200.00K | 100.00K |
| EBITDA | 231.44M | 181.15M | 153.45M | 102.71M | 121.00M | 129.43M | 97.29M | 78.66M | 74.85M | 76.33M | 60.43M | 50.76M | 52.93M | 32.24M | 45.39M | 42.10M | 32.41M | 19.01M | 23.52M | 27.34M | 30.37M | 21.16M | 14.50M | 7.78M | 9.70M | 8.10M | 5.40M | 6.80M | 4.20M | 3.60M | 4.00M | 2.80M | 2.00M | 300.00K | -300.00K |
| EBITDA Ratio | 18.41% | 16.91% | 16.04% | 4.59% | 3.88% | 6.85% | 6.21% | 5.75% | 7.10% | 8.03% | 7.10% | 7.78% | 10.89% | 8.62% | 12.83% | 18.11% | 15.52% | 14.25% | 17.56% | 20.95% | 21.21% | 18.22% | 13.19% | 8.95% | 12.44% | 11.99% | 8.91% | 13.47% | 9.86% | 10.51% | 15.35% | 15.22% | 18.10% | 4.55% | -21.43% |
| Operating Income | 123.94M | 87.56M | 60.92M | -62.58M | -65.71M | 58.62M | 33.07M | 34.88M | 37.54M | 40.17M | 27.84M | 29.64M | 33.19M | 17.20M | 32.85M | 30.98M | 22.97M | 19.01M | 23.52M | 27.34M | 25.63M | 16.78M | 9.94M | 3.46M | 6.10M | 5.30M | 2.70M | 4.40M | 2.50M | 2.00M | 2.60M | 1.70M | 1.50M | 100.00K | -400.00K |
| Operating Income Ratio | 9.86% | 7.61% | 5.67% | -6.49% | -6.60% | 6.64% | 4.54% | 5.78% | 6.92% | 7.88% | 6.20% | 7.52% | 9.23% | 5.80% | 12.76% | 13.64% | 11.06% | 9.97% | 14.12% | 18.06% | 18.85% | 14.43% | 9.55% | 3.78% | 7.82% | 7.75% | 4.46% | 8.71% | 5.87% | 6.01% | 10.24% | 9.24% | 14.29% | 2.27% | -28.57% |
| Total Other Income/Expenses | -11.86M | -19.44M | -7.00M | -11.67M | -13.24M | -9.10M | 2.81M | -9.49M | -6.34M | -8.59M | -8.01M | -2.02M | -315.00K | -416.00K | 247.00K | 861.00K | 429.00K | 174.00K | 379.00K | 666.00K | 885.00K | -13.00K | -151.23K | -2.69M | -1.40M | -1.10M | -1.00M | -900.00K | -600.00K | 100.00K | 0.00 | 0.00 | 200.00K | 0.00 | 400.00K |
| Income Before Tax | 112.09M | 82.63M | 53.92M | -13.23M | 2.19M | 49.52M | 35.88M | 25.39M | 31.20M | 31.57M | 19.84M | 27.62M | 32.88M | 16.79M | 33.09M | 31.85M | 23.40M | 19.18M | 23.90M | 28.01M | 27.02M | 16.76M | 9.79M | 773.85K | 4.70M | 4.20M | 1.70M | 3.50M | 1.90M | 2.10M | 2.60M | 1.70M | 1.70M | 100.00K | -400.00K |
| Income Before Tax Ratio | 8.91% | 7.18% | 5.02% | -1.37% | 0.22% | 5.61% | 4.93% | 4.20% | 5.75% | 6.19% | 4.42% | 7.00% | 9.15% | 5.66% | 12.85% | 14.02% | 11.26% | 10.06% | 14.35% | 18.50% | 19.88% | 14.42% | 9.41% | 0.85% | 6.03% | 6.14% | 2.81% | 6.93% | 4.46% | 6.31% | 10.24% | 9.24% | 16.19% | 2.27% | -28.57% |
| Income Tax Expense | 17.68M | 8.11M | 5.46M | -3.39M | -3.26M | 7.50M | 8.36M | 5.27M | 7.40M | 8.60M | 3.27M | 7.91M | 9.83M | 4.33M | 10.56M | 11.12M | 7.81M | 6.88M | 8.12M | 10.07M | 9.73M | 5.45M | 3.05M | -52.71K | 1.50M | 1.70M | 900.00K | 1.30M | 700.00K | 800.00K | 800.00K | 500.00K | 400.00K | -100.00K | 400.00K |
| Net Income | 94.41M | 74.52M | 48.45M | -9.84M | 5.45M | 42.02M | 27.52M | 20.12M | 23.80M | 22.97M | 16.57M | 19.71M | 23.04M | 12.46M | 22.53M | 20.73M | 15.59M | 12.30M | 15.78M | 17.93M | 17.30M | 11.31M | 6.74M | 826.56K | 3.20M | 2.50M | 800.00K | 2.20M | 1.20M | 1.30M | 1.80M | 1.20M | 1.30M | 100.00K | -400.00K |
| Net Income Ratio | 7.51% | 6.47% | 4.51% | -1.02% | 0.55% | 4.76% | 3.78% | 3.33% | 4.39% | 4.51% | 3.69% | 5.00% | 6.41% | 4.20% | 8.75% | 9.13% | 7.50% | 6.45% | 9.47% | 11.84% | 12.72% | 9.73% | 6.47% | 0.90% | 4.10% | 3.65% | 1.32% | 4.36% | 2.82% | 3.90% | 7.09% | 6.52% | 12.38% | 2.27% | -28.57% |
| EPS | 1.64 | 1.31 | 0.86 | -0.18 | 0.10 | 0.80 | 0.56 | 0.45 | 0.54 | 0.53 | 0.39 | 0.47 | 0.59 | 0.35 | 0.64 | 0.60 | 0.46 | 0.36 | 0.47 | 0.54 | 0.53 | 0.37 | 0.24 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| EPS Diluted | 1.62 | 1.29 | 0.84 | -0.18 | 0.10 | 0.78 | 0.55 | 0.45 | 0.53 | 0.53 | 0.39 | 0.46 | 0.58 | 0.34 | 0.63 | 0.58 | 0.44 | 0.35 | 0.46 | 0.52 | 0.51 | 0.34 | 0.23 | 0.03 | 0.12 | 0.10 | 0.03 | 0.09 | 0.05 | 0.05 | 0.08 | 0.05 | 0.06 | 0.01 | -0.03 |
| Weighted Avg Shares Out | 57.59M | 56.81M | 56.15M | 55.43M | 55.08M | 52.27M | 48.81M | 44.41M | 44.04M | 43.14M | 42.61M | 42.18M | 39.09M | 35.29M | 35.01M | 34.71M | 34.28M | 34.17M | 33.56M | 32.88M | 31.56M | 30.11M | 28.17M | 26.84M | 26.18M | 25.76M | 25.25M | 24.48M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
| Weighted Avg Shares Out (Dil) | 58.36M | 57.67M | 57.36M | 55.43M | 56.24M | 53.93M | 50.10M | 44.86M | 44.51M | 43.41M | 42.88M | 42.61M | 39.73M | 35.98M | 35.76M | 35.69M | 35.26M | 35.31M | 34.81M | 34.61M | 33.79M | 32.80M | 29.84M | 27.29M | 26.27M | 26.00M | 25.25M | 24.59M | 23.15M | 23.76M | 22.32M | 21.93M | 20.52M | 11.57M | 13.89M |
MMSI or WST: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
MMSI Stock Down Despite Latest Positive Data From WRAPSODY WAVE Trial
The significant improvement in patency rates for AVG patients via Merit Medical's WRAPSODY device is expected to enhance patients' vascular access survival.
Fundus Camera Market Global Forecasts and Company Analysis 2025-2033, Profiles of Carl Zeiss Medites, Topcon Medical Systems, Merit Medical Systems, NIDEK, and Revenio Group
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Fundus Camera Market Global Forecast Report by Product Type, End-User, Countries and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Fundus Camera market was valued at US$459.40 million in...
Merit Medical's WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial
3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?
MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BDX or MMSI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Merit Medical (MMSI) possesses solid growth attributes, which could help it handily outperform the market.
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Source: https://incomestatements.info
Category: Stock Reports